80 results
Page 3 of 4
8-K
EX-10.2
s4smh2
6 Jan 21
Ameri Holdings Announces 1-FOR-4 Reverse Stock Split
5:10pm
8-K
EX-3.3
h8d2cg
6 Jan 21
Ameri Holdings Announces 1-FOR-4 Reverse Stock Split
5:10pm
8-K
EX-10.1
4ecp5 wo60j93fep
6 Jan 21
Ameri Holdings Announces 1-FOR-4 Reverse Stock Split
5:10pm
8-K
EX-10.3
pwj7es9cc8s7zmhjotut
6 Jan 21
Ameri Holdings Announces 1-FOR-4 Reverse Stock Split
5:10pm
S-4MEF
EX-8.2
prbte53 x5e8hpe
28 Dec 20
Addition of securities to prior registration
5:30pm
S-4MEF
EX-8.1
p5lhj6ndvr dpj8
28 Dec 20
Addition of securities to prior registration
5:30pm
8-K
EX-10.1
gmxnx 9n3ggpkd2aa
11 Sep 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.2
wu32ptz
11 Sep 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
u7bxq1 sv
12 Aug 20
Entry into a Material Definitive Agreement
5:19pm
8-K
EX-4.1
skjcvnybbk kdwuyms
3 Aug 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
z4k2uo1l3 1n0h076l
3 Aug 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.3
40x3dhxda5a
4 Jun 20
Ameri Holdings Amalgamation Partner Jay Pharma Reports Irb Approval for Testing Proprietary CBD Formulation In Brain Cancer
9:00am
8-K
EX-10.2
lfh6apwk
4 Jun 20
Ameri Holdings Amalgamation Partner Jay Pharma Reports Irb Approval for Testing Proprietary CBD Formulation In Brain Cancer
9:00am
8-K
EX-10.1
lqxy0j8
4 Jun 20
Ameri Holdings Amalgamation Partner Jay Pharma Reports Irb Approval for Testing Proprietary CBD Formulation In Brain Cancer
9:00am